Treatment Strategy for Petroclival Meningiomas Based on a Proposed Classification in a Study of 168 Cases

Zijin Zhao(Central South University), Qing Liu(Central South University), Siyi Wanggou(Central South University), Haoyu Li(Qingdao University), Zefeng Peng(Central South University), Xianrui Yuan(Shandong Normal University), Xuejun Li(Central South University), Li Cai(Anhui Medical University), Guodong Tang(Central South University), Yuanyang Xie(King's College London), Weixi Jiang(Central South University), Chi Zhang(Jiangmen Polytechnic), Jian Yuan(Tongji University)
Scientific Reports
March 13, 2020
10.1038/s41598-020-61497-y
Cited by 32

Related Papers

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Metabolic regulation of homologous recombination repair by MRE11 lactylation
|Cell|2023|374
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
|Nature Communications|2022|243
A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
|The Journal of Cell Biology|2009|233
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167